ATE255407T1 - Pharmazeutische zusammensetzungen, die terbinafin enthalten - Google Patents

Pharmazeutische zusammensetzungen, die terbinafin enthalten

Info

Publication number
ATE255407T1
ATE255407T1 AT01925320T AT01925320T ATE255407T1 AT E255407 T1 ATE255407 T1 AT E255407T1 AT 01925320 T AT01925320 T AT 01925320T AT 01925320 T AT01925320 T AT 01925320T AT E255407 T1 ATE255407 T1 AT E255407T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions containing
terbinafin
containing terbinafin
composition
Prior art date
Application number
AT01925320T
Other languages
English (en)
Inventor
Jean-Daniel Bonny
Andreas Carl Eugster
Patrice Guitard
Stefan Hirsch
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE255407T1 publication Critical patent/ATE255407T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01925320T 2000-01-27 2001-01-25 Pharmazeutische zusammensetzungen, die terbinafin enthalten ATE255407T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0001928.1A GB0001928D0 (en) 2000-01-27 2000-01-27 Organic compounds
PCT/EP2001/000834 WO2001054675A2 (en) 2000-01-27 2001-01-25 Pharmaceutical compositions comprising terbinafine

Publications (1)

Publication Number Publication Date
ATE255407T1 true ATE255407T1 (de) 2003-12-15

Family

ID=9884486

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01925320T ATE255407T1 (de) 2000-01-27 2001-01-25 Pharmazeutische zusammensetzungen, die terbinafin enthalten

Country Status (12)

Country Link
US (4) US20090143479A1 (de)
EP (1) EP1250125B1 (de)
JP (1) JP5036114B2 (de)
AT (1) ATE255407T1 (de)
AU (1) AU5211901A (de)
DE (1) DE60101370T2 (de)
DK (1) DK1250125T3 (de)
ES (1) ES2211797T3 (de)
GB (1) GB0001928D0 (de)
PT (1) PT1250125E (de)
TR (1) TR200400314T4 (de)
WO (1) WO2001054675A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8535650B2 (en) * 2001-12-03 2013-09-17 Soligenix, Inc. Stabilized reverse micelle compositions and uses thereof
JP2005104924A (ja) * 2003-09-30 2005-04-21 Kobayashi Pharmaceut Co Ltd 外用医薬組成物
FR2861992B1 (fr) * 2003-11-10 2007-07-20 Sanofi Synthelabo Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
CN101467960B (zh) * 2007-12-29 2012-11-28 浙江康恩贝制药股份有限公司 一种盐酸特比萘芬乳膏及其制备方法
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
KR101623928B1 (ko) * 2015-02-24 2016-05-24 한양대학교 에리카산학협력단 자가나노유화 약물 전달시스템을 이용한 에제티미브의 경구용 고형제제 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3694557A (en) * 1970-10-23 1972-09-26 Amazon Natural Drug Co The Anti-inflammation compositions containing taspine or acid salts thereof and method of use
JPS5913717A (ja) * 1982-07-16 1984-01-24 Asahi Chem Ind Co Ltd エマルジヨン製剤
ATE100675T1 (de) * 1987-06-15 1994-02-15 Sbp Inc Esswaren enthaltend parenchymzellen-zellulose.
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
JPH10338613A (ja) * 1997-06-06 1998-12-22 Pola Chem Ind Inc 透明化粧料
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
DE69823663T2 (de) * 1997-07-29 2005-05-19 Pharmacia & Upjohn Co., Kalamazoo Selbstemulgierbare formulierung enthaltend lipophile verbindungen
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions

Also Published As

Publication number Publication date
TR200400314T4 (tr) 2004-03-22
ES2211797T3 (es) 2004-07-16
JP5036114B2 (ja) 2012-09-26
DE60101370T2 (de) 2004-10-28
DE60101370D1 (de) 2004-01-15
EP1250125B1 (de) 2003-12-03
US20120244194A1 (en) 2012-09-27
US20130236514A1 (en) 2013-09-12
WO2001054675A2 (en) 2001-08-02
JP2003521495A (ja) 2003-07-15
PT1250125E (pt) 2004-04-30
GB0001928D0 (en) 2000-03-22
EP1250125A2 (de) 2002-10-23
AU5211901A (en) 2001-08-07
WO2001054675A3 (en) 2002-02-14
US20090143479A1 (en) 2009-06-04
DK1250125T3 (da) 2004-03-29
US20110086071A1 (en) 2011-04-14

Similar Documents

Publication Publication Date Title
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
HUP0203176A2 (hu) Szimetikont tartalmazó orális, szilárd adagolási forma
PA8518801A1 (es) Derivados de 2-aminocarbonil-9h-purina
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
CY1113462T1 (el) Μορφη δοσολογιας περιεχουσα παντοπραζολη ως δραστικο συστατικο
MA27921A1 (fr) Systemes emulsifiants contenant des derives d'azetidine
NO20034863L (no) Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser
HN2001000262A (es) Kit de repinotano
FR2849992B1 (fr) Composition pour une administration par voie orale contenant des capsaicinoides
ATE255407T1 (de) Pharmazeutische zusammensetzungen, die terbinafin enthalten
BRPI0408848A (pt) formulações orais de cladribine
CL2004001421A1 (es) Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor.
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
CY1106964T1 (el) Φαρμακα που περιεχουν ν,ν’-διυποκατεστημενες ενωσεις πιπεραζινης και η χρησιμοποιηση τους
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
DE69802943D1 (de) Arzneizubereitung zur verabreichung von thiocolchicosid durch die mundschleimhaut
SE0403117D0 (sv) New compounds 1
BR0001144B1 (pt) Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase
ATE298564T1 (de) Arzneimittelformulierung enthaltend einen ltb4 antagonisten und einen netzmittel
ECSP034549A (es) Formas cristalinas de 1-(6-cloro-5-(trifluorometil)-2-piridinil)piperazina hidrocloruro

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1250125

Country of ref document: EP